The yin and yang of GSM and low sexual desire

References

• Flynn KE, Lin L, Bruner DW, et al. Sexual satisfaction and the importance of sexual health to quality of life throughout the life course of U.S. Adults. J Sex Med. 2016;13(11):1642–1650.
   PubMed Web of Science ®Google Scholar
• Cain VS, Johannes CB, Avis NE, et al. Sexual functioning and practices in a multi-ethnic study of midlife women: baseline results from SWAN. J Sex Res. 2003;40(3):266–276.
   PubMed Web of Science ®Google Scholar
• Kingsberg SA, Schaffir J, Faught BM, et al. Female sexual health: barriers to optimal outcomes and a roadmap for improved patient-clinician communications. J Womens Health. 2019;28(4):432–443.
   PubMed Web of Science ®Google Scholar
• Takayesu J, Dess RT, Evans J, et al. Evaluation of disparity in physician assessment of sexual dysfunction in women versus men receiving brachytherapy for genitourinary cancers. Poster presented at the 64th annual ASTRO meeting; 2022.
   Google Scholar
• Simon JA, Athavale A, Ravindranath R, et al. Assessing the burden of illness associated with acquired generalized hypoactive sexual desire disorder. J Womens Health. 2022;31(5):715–725.
   Web of Science ®Google Scholar
• Thomas HN, Hess R, Thurston RC. Correlates of sexual activity and satisfaction in midlife and older women. Ann Fam Med. 2015;13(4):336–342.
   PubMed Web of Science ®Google Scholar
• Schneidewind-Skibbe A, Hayes RD, Koochaki PE, et al. The frequency of sexual intercourse reported by women: a review of community-based studies and factors limiting their conclusions. J Sex Med. 2008;5(2):301–335.
   PubMed Web of Science ®Google Scholar
• Fisher L, Anderson O, Chapagain M, et al. Sex, romance, and relationships. Shington, D.C.: WA; 2009.
   Google Scholar
• Parish SJ, Hahn SR, Goldstein SW, et al. The international society for the study of women’s sexual health process of care for the identification of sexual concerns and problems in women. Mayo Clin Proc. 2019;94(5):842–856.
   PubMed Web of Science ®Google Scholar
• Clayton AH, Goldfischer ER, Goldstein I, et al. Validation of the decreased sexual desire screener (DSDS): a brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD). J Sex Med. 2009;6(3):730–738.
   PubMed Web of Science ®Google Scholar
• Annon J. The PLISSIT model: a proposed conceptual scheme for the beha-vioural treatment of sexual problems. J Sex Educ Ther. 1976;2:1–15.
   Google Scholar
• Kingsberg SA, Althof S, Simon JA, et al. Female sexual dysfunction-medical and psychological treatments, committee 14. J Sex Med. 2017;14(12):1463–1491.
   PubMed Web of Science ®Google Scholar
• Parish SJ, Goldstein AT, Goldstein SW, et al. Toward a more evidence-based nosology and nomenclature for female sexual dysfunctions-part II. J Sex Med. 2016;13(12):1888–1906.
   PubMedGoogle Scholar
• Shifren JL, Monz BU, Russo PA, et al. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol. 2008;112(5):970–978.
   PubMed Web of Science ®Google Scholar
• Clayton AH, Goldstein I, Kim NN, et al. The international society for the study of women’s sexual health process of care for management of hypoactive sexual desire disorder in women. Mayo Clin Proc. 2018;93(4):467–487.
   PubMed Web of Science ®Google Scholar
• Atlantis E, Sullivan T. Bidirectional association between depression and sexual dysfunction: a systematic review and meta-analysis. J Sex Med. 2012;9(6):1497–1507.
   PubMed Web of Science ®Google Scholar
• Lorenz T, Rullo J, Faubion S. Antidepressant-induced female sexual dysfunction. Mayo Clin Proc. 2016;91(9):1280–1286.
   PubMed Web of Science ®Google Scholar
• The 2020 genitourinary syndrome of menopause position statement of the North American menopause society. Menopause. 2020;27(9):976–992.
   PubMed Web of Science ®Google Scholar
• Krychman M, Graham S, Bernick B, et al. The women’s empower survey: women’s knowledge and awareness of treatment options for vulvar and vaginal atrophy remains inadequate. J Sex Med. 2017;14(3):425–433.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Kingsberg S, Maamari R, et al. The CLOSER (CLarifying vaginal atrophy’s impact on SEx and relationships) survey: implications of vaginal discomfort in postmenopausal women and in male partners. J Sex Med. 2013;10(9):2232–2241.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Kokot-Kierepa M. Vaginal health: insights, views & attitudes (VIVA) – results from an international survey. Climacteric. 2012;15(1):36–44.
   PubMed Web of Science ®Google Scholar
• Moral E, Delgado JL, Carmona F, et al. The impact of genitourinary syndrome of menopause on well-being, functioning, and quality of life in postmenopausal women. Menopause. 2018;25(12):1418–1423.
   PubMed Web of Science ®Google Scholar
• McCarthy BW. Relapse prevention strategies and techniques for inhibited sexual desire. J Sex Marital Ther. 1999;25(4):297–303.
   PubMed Web of Science ®Google Scholar
• Parish SJ, Faubion SS, Weinberg M, et al. The MATE survey: men’s perceptions and attitudes towards menopause and their role in partners’ menopausal transition. Menopause. 2019;26(10):1110–1116.
   PubMed Web of Science ®Google Scholar
• Pyke RE, Clayton AH. Psychological treatment trials for hypoactive sexual desire disorder: a sexual medicine critique and perspective. J Sex Med. 2015;12(12):2451–2458.
   PubMed Web of Science ®Google Scholar
• Kingsberg S, Althof S. Psychological management of hypoactive sexual desire disorder. In: Goldstein I, Clayton A, Goldstein AT, Kim NN, Kingsberg S, editors. Textbook of female sexual function and dysfunction. New York: John Wiley & Sons Ltd.; 2018.
   Google Scholar
• Mercier J, Morin M, Zaki D, et al. Pelvic floor muscle training as a treatment for genitourinary syndrome of menopause: a single-arm feasibility study. Maturitas. 2019;125:57–62.
   PubMed Web of Science ®Google Scholar
• Kanter G, Rogers RG, Pauls RN, et al. A strong pelvic floor is associated with higher rates of sexual activity in women with pelvic floor disorders. Int Urogynecol J. 2015;26(7):991–996.
   PubMed Web of Science ®Google Scholar
• Jang YC, Leung CY, Huang HL. Comparison of severity of genitourinary syndrome of menopause symptoms after carbon dioxide laser vs vaginal estrogen therapy: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(9):e2232563.
   PubMed Web of Science ®Google Scholar
• Filippini M, Luvero D, Salvatore S, et al. Efficacy of fractional CO2 laser treatment in postmenopausal women with genitourinary syndrome: a multicenter study. Menopause. 2020;27(1):43–49.
   PubMed Web of Science ®Google Scholar
• Salvatore S, Pitsouni E, Grigoriadis T, et al. CO2 laser and the genitourinary syndrome of menopause: a randomized sham-controlled trial. Climacteric. 2021;24(2):187–193.
   PubMed Web of Science ®Google Scholar
• Pfaus JG. Pathways of sexual desire. J Sex Med. 2009;6(6):1506–1533.
   PubMed Web of Science ®Google Scholar
• Addyi package insert. Sprout Pharmaceuticals, Inc.; 2023.
   Google Scholar
• Baid R, Agarwal R. Flibanserin: a controversial drug for female hypoactive sexual desire disorder. Ind Psychiatry J. 2018;27(1):154–157.
   PubMedGoogle Scholar
• Simon JA, Kingsberg SA, Goldstein I, et al. Weight loss in women taking flibanserin for hypoactive sexual desire disorder (HSDD): insights into potential mechanisms. Sex Med Rev. 2019;7(4):575–586.
   PubMed Web of Science ®Google Scholar
• Bremelanotide package insert. Cranberry, NJ: Palatin Technologies; 2023.
   Google Scholar
• Davis SR, Baber R, Panay N, et al. Global consensus position statement on the use of testosterone therapy for women. J Clin Endocrinol Metab. 2019;104(10):4660–4666.
   PubMed Web of Science ®Google Scholar
• Parish SJ, Simon JA, Davis SR, et al. International society for the study of women’s sexual health clinical practice guideline for the use of systemic testosterone for hypoactive sexual desire disorder in women. J Womens Health. 2021;30(4):474–491.
   Web of Science ®Google Scholar
• Islam RM, Bell RJ, Green S, et al. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Lancet Diabetes Endocrinol. 2019;7(10):754–766.
   PubMed Web of Science ®Google Scholar